Table 1.
Demographic information of subjects.
| Subject | Gender | Age | Amblyopic type | Amblyopic eye | CVA (logMAR) | History of treatment | |
|---|---|---|---|---|---|---|---|
| OD | OS | ||||||
| Amb 01 | F | 12 | ANA | OS | -0.1 | 0.7 | None |
| Amb 02 | M | 5 | ANA | OS | 0.1 | 0.4 | None |
| Amb 03 | F | 14 | ANA | OS | 0.0 | 1.0 | None |
| Amb 04 | M | 8 | AMA | OS | -0.1 | 0.5 | None |
| Amb 05 | M | 6 | ANA; AMA | OS | 0.0 | 1.0 | None |
| Amb 06 | M | 13 | ANA | OS | 0.0 | 0.4 | None |
| Amb 07 | M | 8 | ANA; AMA | OS | 0.1 | 0.7 | None |
| Amb 08 | M | 10 | ANA; AMA | OS | 0.0 | 0.7 | None |
| Amb 09 | F | 14 | ANA; AMA | OS | 0.0 | 0.5 | None |
| Amb 10 | M | 12 | ANA | OS | 0.0 | 1.2 | None |
| Amb 11 | F | 8 | ANA | OS | 0.0 | 0.7 | None |
| Amb 12 | M | 24 | AMA | OS | 0.0 | 0.2 | None |
| Amb 13 | M | 15 | AMA | OS | 0.0 | 0.5 | None |
| Control 01 | F | 6 | None | None | 0.2 | 0.1 | None |
| Control 02 | F | 24 | None | None | 0.0 | 0.0 | None |
| Control 03 | F | 12 | None | None | 0.0 | 0.0 | None |
| Control 04 | F | 12 | None | None | 0.0 | 0.0 | None |
| Control 05 | M | 9 | None | None | 0.0 | 0.0 | None |
| Control 06 | F | 8 | None | None | 0.0 | 0.0 | None |
| Control 07 | M | 13 | None | None | 0.0 | 0.0 | None |
| Control 08 | M | 14 | None | None | 0.0 | 0.0 | None |
| Control 09 | F | 14 | None | None | -0.2 | -0.1 | None |
| Control 10 | F | 11 | None | None | 0.0 | 0.0 | None |
| Control 11 | M | 10 | None | None | -0.1 | -0.2 | None |
| Control 12 | M | 7 | None | None | 0.0 | -0.1 | None |
| Control 13 | M | 10 | None | None | -0.2 | -0.1 | None |
Note: Amb: amblyopia group; F: female; M: male; CVA: corrected visual acuity; OD: oculus dexter; OS: oculus sinister; ANA: anisometropic amblyopia; AMA: ametropic amblyopia.